BASi Opens new Facility in Europe to Better Serve Pharmaceutical and Biotech Companies
News Jun 18, 2009
BASi has opened a new European laboratory and office in Warwickshire, UK. The relocation to a new, upgraded facility with expanded laboratories provides clients with enhanced capabilities throughout Europe.
Like its North American counterparts, the new 10,000 square foot facility offers a comprehensive bioanalytical capability, as well as providing access to the BASi Group’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies.
BASi Europe also supplies the complete line of BASi instruments and equipment, including the Culex Automated In Vivo Sampling System, as well as providing support for customers and distributors throughout Europe.
“BASi Europe offers over a thousand established and validated analytical methods and procedures,” said Mark Wareing, managing director of BASi Europe.
“We currently have multiple industry standard LC-MS/MS stations, as well as LC-EC and other analytical technologies, and we have invested in two more high-sensitivity MS/MS instruments with state-of-the-art front-end analytical systems. We offer complete peace of mind with an enviable track record of delivering internationally compliant GLP/GCP regulated studies.”
Synthetic biologists look to re-engineer cells to make complex molecules for specific needs, including pharmaceuticals. But the trial-and-error process is difficult and time-consuming. Now, by combining two state-of-the-art research approaches, researchers have created a fast, efficient way to engineer and analyze metabolic pathways.READ MORE